The present application provides an immunity-inducing agent which includes, as an active ingredient: at least one polypeptide which exhibits immunity-inducing activity, and which is selected from (a) polypeptides comprising the amino acid sequences represented by SEQ. ID NO. 8, 4, 6, 10, 12, 2, and 14 in the sequence listing, and polypeptides comprising at least 7 continuous amino acids in said amino acid sequences, (b) polypeptides exhibiting at least 85% sequence identity with the amino acid sequences represented by SEQ. ID NO. 8, 4, 6, 10, 12, 2, and 14, and polypeptides comprising at least 7 continuous amino acids in the amino acid sequences of said polypeptides, and (c) polypeptides including, as part of the sequences thereof, any of the polypeptides in (a) and (b)； or a recombinant vector which includes a polynucleotide encoding the abovementioned at least one polypeptide, and which is capable of expressing said polypeptide in vivo.
